Wednesday, July 8, 2026

pharma · MAC Lung Disease · Mycobacterium Abscessus Infection · ANTX

AN2 Therapeutics

AN2 Therapeutics trial registry — 6 ClinicalTrials.gov studies with program phase, status, and indication context.

Menlo Park, USA HQ
2019 Founded
35 Employees
Public company Type
ANTX · NYSE Ticker
Company details
Status
Public
HQ
Menlo Park, USA
Founded
2019
Employees
35
Programs
6
Drugs
2
Patents
0
Intelligence · Clinical Trials

AN2 Therapeutics clinical trials

Registry index of 6 ClinicalTrials.gov studies linked to AN2 Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

AN2 Therapeutics trial registry — 6 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

6 updates

Latest clinical program signals indexed for AN2 Therapeutics.

  1. Epetraborole and matching placebo — Phase 1

    Clinical update
  2. AN2-502998 — Phase 1

    Clinical update
  3. Epetraborole — Phase 3

    Clinical update
  4. Epetraborole — Phase 2

    Clinical update
  5. Epetraborole — Phase 1

    Clinical update
  6. Epetraborole — Phase 1

    Clinical update

Trial registry

6 studies